|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010592,
umls-concept:C0022671,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0205360,
umls-concept:C0332835,
umls-concept:C0542341,
umls-concept:C0699605,
umls-concept:C0733686,
umls-concept:C1261322,
umls-concept:C1314677,
umls-concept:C1516634
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-8-13
|
|
pubmed:abstractText |
Previous pharmacokinetic studies have demonstrated bioequivalence of Imusporin (microemulsion preparation of cyclosporine, Cipla) to the innovator product Neoral (Novartis, Switzerland). This study was done to evaluate the clinical efficacy and safety of Imusporin in patients who have already undergone renal transplant and have stable graft function maintained on cyclosporine preparation other than Imusporin.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:status |
PubMed-not-MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0970-1591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
130-2
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Clinical evaluation of efficacy and safety of cyclosporine (Imusporin) in renal transplant patients with stable graft function maintained on neoral or bioral.
|
|
pubmed:affiliation |
Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, UP, India.
|
|
pubmed:publicationType |
Journal Article
|
